Chapter/Section Purchase

1 Uterine Fibroid Embolization Device Market Overview
1.1 Product Overview and Scope of Uterine Fibroid Embolization Device
1.2 Uterine Fibroid Embolization Device Segment by Type
1.2.1 Global Uterine Fibroid Embolization Device Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Gelatin Sponge
1.2.3 Polyvinyl Alcohol ( PVA ) Particles
1.2.4 Trisacryl Gelatin Microspheres ( TAGM )
1.2.5 Polymethyl Methacrylate ( PMMA ) Microspheres
1.3 Uterine Fibroid Embolization Device Segment by Application
1.3.1 Global Uterine Fibroid Embolization Device Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Uterine Fibroid Embolization Device Market Size Estimates and Forecasts
1.4.1 Global Uterine Fibroid Embolization Device Revenue 2017-2028
1.4.2 Global Uterine Fibroid Embolization Device Sales 2017-2028
1.4.3 Uterine Fibroid Embolization Device Market Size by Region: 2017 Versus 2021 Versus 2028
2 Uterine Fibroid Embolization Device Market Competition by Manufacturers
2.1 Global Uterine Fibroid Embolization Device Sales Market Share by Manufacturers (2017-2022)
2.2 Global Uterine Fibroid Embolization Device Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Uterine Fibroid Embolization Device Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Uterine Fibroid Embolization Device Manufacturing Sites, Area Served, Product Type
2.5 Uterine Fibroid Embolization Device Market Competitive Situation and Trends
2.5.1 Uterine Fibroid Embolization Device Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Uterine Fibroid Embolization Device Players Market Share by Revenue
2.5.3 Global Uterine Fibroid Embolization Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Uterine Fibroid Embolization Device Retrospective Market Scenario by Region
3.1 Global Uterine Fibroid Embolization Device Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Uterine Fibroid Embolization Device Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Uterine Fibroid Embolization Device Market Facts & Figures by Country
3.3.1 North America Uterine Fibroid Embolization Device Sales by Country
3.3.2 North America Uterine Fibroid Embolization Device Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Uterine Fibroid Embolization Device Market Facts & Figures by Country
3.4.1 Europe Uterine Fibroid Embolization Device Sales by Country
3.4.2 Europe Uterine Fibroid Embolization Device Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Uterine Fibroid Embolization Device Market Facts & Figures by Region
3.5.1 Asia Pacific Uterine Fibroid Embolization Device Sales by Region
3.5.2 Asia Pacific Uterine Fibroid Embolization Device Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Uterine Fibroid Embolization Device Market Facts & Figures by Country
3.6.1 Latin America Uterine Fibroid Embolization Device Sales by Country
3.6.2 Latin America Uterine Fibroid Embolization Device Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Uterine Fibroid Embolization Device Market Facts & Figures by Country
3.7.1 Middle East and Africa Uterine Fibroid Embolization Device Sales by Country
3.7.2 Middle East and Africa Uterine Fibroid Embolization Device Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Uterine Fibroid Embolization Device Historic Market Analysis by Type
4.1 Global Uterine Fibroid Embolization Device Sales Market Share by Type (2017-2022)
4.2 Global Uterine Fibroid Embolization Device Revenue Market Share by Type (2017-2022)
4.3 Global Uterine Fibroid Embolization Device Price by Type (2017-2022)
5 Global Uterine Fibroid Embolization Device Historic Market Analysis by Application
5.1 Global Uterine Fibroid Embolization Device Sales Market Share by Application (2017-2022)
5.2 Global Uterine Fibroid Embolization Device Revenue Market Share by Application (2017-2022)
5.3 Global Uterine Fibroid Embolization Device Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Boston Scientific Corporation
6.1.1 Boston Scientific Corporation Corporation Information
6.1.2 Boston Scientific Corporation Description and Business Overview
6.1.3 Boston Scientific Corporation Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Boston Scientific Corporation Uterine Fibroid Embolization Device Product Portfolio
6.1.5 Boston Scientific Corporation Recent Developments/Updates
6.2 Merit Medical Systems
6.2.1 Merit Medical Systems Corporation Information
6.2.2 Merit Medical Systems Description and Business Overview
6.2.3 Merit Medical Systems Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Merit Medical Systems Uterine Fibroid Embolization Device Product Portfolio
6.2.5 Merit Medical Systems Recent Developments/Updates
6.3 BioSpace
6.3.1 BioSpace Corporation Information
6.3.2 BioSpace Description and Business Overview
6.3.3 BioSpace Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2017-2022)
6.3.4 BioSpace Uterine Fibroid Embolization Device Product Portfolio
6.3.5 BioSpace Recent Developments/Updates
6.4 Hologic, Inc.
6.4.1 Hologic, Inc. Corporation Information
6.4.2 Hologic, Inc. Description and Business Overview
6.4.3 Hologic, Inc. Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Hologic, Inc. Uterine Fibroid Embolization Device Product Portfolio
6.4.5 Hologic, Inc. Recent Developments/Updates
6.5 Cook Medical
6.5.1 Cook Medical Corporation Information
6.5.2 Cook Medical Description and Business Overview
6.5.3 Cook Medical Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Cook Medical Uterine Fibroid Embolization Device Product Portfolio
6.5.5 Cook Medical Recent Developments/Updates
6.6 Ferring B.V.
6.6.1 Ferring B.V. Corporation Information
6.6.2 Ferring B.V. Description and Business Overview
6.6.3 Ferring B.V. Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Ferring B.V. Uterine Fibroid Embolization Device Product Portfolio
6.6.5 Ferring B.V. Recent Developments/Updates
6.7 Smith+Nephew
6.6.1 Smith+Nephew Corporation Information
6.6.2 Smith+Nephew Description and Business Overview
6.6.3 Smith+Nephew Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Smith+Nephew Uterine Fibroid Embolization Device Product Portfolio
6.7.5 Smith+Nephew Recent Developments/Updates
6.8 CooperSurgical, Inc.
6.8.1 CooperSurgical, Inc. Corporation Information
6.8.2 CooperSurgical, Inc. Description and Business Overview
6.8.3 CooperSurgical, Inc. Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2017-2022)
6.8.4 CooperSurgical, Inc. Uterine Fibroid Embolization Device Product Portfolio
6.8.5 CooperSurgical, Inc. Recent Developments/Updates
6.9 Aetna Better Health of Pennsylvania
6.9.1 Aetna Better Health of Pennsylvania Corporation Information
6.9.2 Aetna Better Health of Pennsylvania Description and Business Overview
6.9.3 Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Product Portfolio
6.9.5 Aetna Better Health of Pennsylvania Recent Developments/Updates
6.10 Ethicon US, LLC
6.10.1 Ethicon US, LLC Corporation Information
6.10.2 Ethicon US, LLC Description and Business Overview
6.10.3 Ethicon US, LLC Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Ethicon US, LLC Uterine Fibroid Embolization Device Product Portfolio
6.10.5 Ethicon US, LLC Recent Developments/Updates
6.11 Olympus America
6.11.1 Olympus America Corporation Information
6.11.2 Olympus America Uterine Fibroid Embolization Device Description and Business Overview
6.11.3 Olympus America Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Olympus America Uterine Fibroid Embolization Device Product Portfolio
6.11.5 Olympus America Recent Developments/Updates
6.12 Stryker
6.12.1 Stryker Corporation Information
6.12.2 Stryker Uterine Fibroid Embolization Device Description and Business Overview
6.12.3 Stryker Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Stryker Uterine Fibroid Embolization Device Product Portfolio
6.12.5 Stryker Recent Developments/Updates
6.13 Astellas Pharma
6.13.1 Astellas Pharma Corporation Information
6.13.2 Astellas Pharma Uterine Fibroid Embolization Device Description and Business Overview
6.13.3 Astellas Pharma Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Astellas Pharma Uterine Fibroid Embolization Device Product Portfolio
6.13.5 Astellas Pharma Recent Developments/Updates
6.14 Nippon Kayaku
6.14.1 Nippon Kayaku Corporation Information
6.14.2 Nippon Kayaku Uterine Fibroid Embolization Device Description and Business Overview
6.14.3 Nippon Kayaku Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Nippon Kayaku Uterine Fibroid Embolization Device Product Portfolio
6.14.5 Nippon Kayaku Recent Developments/Updates
6.15 Pfizer
6.15.1 Pfizer Corporation Information
6.15.2 Pfizer Uterine Fibroid Embolization Device Description and Business Overview
6.15.3 Pfizer Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Pfizer Uterine Fibroid Embolization Device Product Portfolio
6.15.5 Pfizer Recent Developments/Updates
7 Uterine Fibroid Embolization Device Manufacturing Cost Analysis
7.1 Uterine Fibroid Embolization Device Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Uterine Fibroid Embolization Device
7.4 Uterine Fibroid Embolization Device Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Uterine Fibroid Embolization Device Distributors List
8.3 Uterine Fibroid Embolization Device Customers
9 Uterine Fibroid Embolization Device Market Dynamics
9.1 Uterine Fibroid Embolization Device Industry Trends
9.2 Uterine Fibroid Embolization Device Market Drivers
9.3 Uterine Fibroid Embolization Device Market Challenges
9.4 Uterine Fibroid Embolization Device Market Restraints
10 Global Market Forecast
10.1 Uterine Fibroid Embolization Device Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Uterine Fibroid Embolization Device by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Uterine Fibroid Embolization Device by Type (2023-2028)
10.2 Uterine Fibroid Embolization Device Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Uterine Fibroid Embolization Device by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Uterine Fibroid Embolization Device by Application (2023-2028)
10.3 Uterine Fibroid Embolization Device Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Uterine Fibroid Embolization Device by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Uterine Fibroid Embolization Device by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer